	US 12,349,675 B2
	Colloidal particle formulations with advanced functionality
Anka Veleva, Cary, NC (US)
Assigned to BENANOVA INC., Cary, NC (US)
Filed by BENANOVA INC., Cary, NC (US)
Filed on Dec. 23, 2020, as Appl. No. 17/247,808.
Claims priority of provisional application 62/975,288, filed on Feb. 12, 2020.
Prior Publication US 2021/0244022 A1, Aug. 12, 2021
Int. Cl. A01N 25/22 (2006.01); A01N 25/04 (2006.01); A01N 25/10 (2006.01); A01N 59/20 (2006.01); C07G 1/00 (2011.01); C08L 97/00 (2006.01)

CPC A01N 25/22 (2013.01) [A01N 25/04 (2013.01); A01N 25/10 (2013.01); A01N 59/20 (2013.01); C07G 1/00 (2013.01); C08L 97/00 (2013.01); C08L 97/005 (2013.01)]

13 Claims

1. A composite colloidal particle formulation ready for administration to treat or prevent disease in plants comprising:

a solid colloidal particle dispersed in a volume of a polyelectrolyte solution,

wherein the solid colloidal particle is plant-derived and comprises a lignin or modified hydrophobic lignin, and

wherein the volume of polyelectrolyte solution is a liquid continuous phase and comprises a chitosan, water, and ethanol,

wherein the formulation is fully biodegradable.